{{Rsnum
|rsid=493573
|Gene=MAP4K2
|Chromosome=11
|position=64789582
|Orientation=plus
|GMAF=0.004591
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=MAP4K2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 100.0 | 0.0 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 96.6 | 3.4 | 0.0
| ASW | 96.5 | 3.5 | 0.0
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 96.4 | 3.6 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 98.7 | 1.3 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=21768215
|Trait=None
|Title=Genome-wide association study for serum urate concentrations and gout among African Americans identifies genomic risk loci and a novel URAT1 loss-of-function allele.
|RiskAllele=A
|Pval=2E-17
|OR=0.8000
|ORtxt=[NR] mg/dl decrease
|OA=1
}}

{{on chip | Illumina Human 1M}}